Charles Frankel
Gastroenterology · Santa Monica, CANPI 1558310805
Payments from drug & device makers
Across 177 payments — averaging $19.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$493
- Bristol Myers Squibb$336
- Braintree Laboratories, Inc.$194
- Takeda Pharmaceuticals U.S.A., Inc.$189
- Sanofi$176
- plus $1K from 17 others
What the payments were for
- Consulting fees$431%
- Food & beverage$3,30195%
- Education$221%
- Gifts$1254%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 55 | $1,079 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 26 | $493 |
| Bristol Myers Squibb | 25 | $336 |
| Braintree Laboratories, Inc. | 6 | $194 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $189 |
| Sanofi | 3 | $176 |
| Pfizer | 7 | $156 |
| Johnson & Johnson | 6 | $131 |
| Intercept Pharmaceuticals, Inc. | 5 | $98 |
| Ardelyx, Inc. | 3 | $95 |
| Regeneron Healthcare Solutions, Inc. | 5 | $85 |
| Madrigal Pharmaceuticals | 4 | $82 |
| Merck | 4 | $75 |
| Phathom Pharmaceuticals, Inc. | 3 | $56 |
| Aimmune Therapeutics, Inc. | 2 | $48 |
| Ironwood Pharmaceuticals, Inc | 2 | $38 |
| Amgen | 1 | $35 |
| Gilead | 1 | $33 |
| Ferring Pharmaceuticals Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $22 |
| Ipsen Biopharmaceuticals, Inc | 1 | $21 |
| QOL Medical, LLC | 1 | $17 |
| Romark Laboratories, LC | 2 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$144
How this compares
$3,491 in reported general payments places this provider in the 55th percentile of 1,885 gastroenterology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XifaxanRifaximin | 24 | $53,640 |
| LinzessLinaclotide | 61 | $32,579 |
| Dexlansoprazole DrDexlansoprazole | 66 | $13,453 |
| VoqueznaVonoprazan Fumarate | 15 | $9,200 |
| MotegrityPrucalopride Succinate | 15 | $7,734 |
| TrulancePlecanatide | 13 | $7,053 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 87 | $5,162 |
| Lubiprostone | 11 | $3,951 |
| Mesalamine | 11 | $3,532 |
| Famotidine | 193 | $2,127 |
| Omeprazole | 148 | $1,440 |
| Pantoprazole Sodium | 135 | $1,409 |
| Esomeprazole Magnesium | 19 | $1,376 |
| Ursodiol | 11 | $524 |
| Neomycin Sulfate | 20 | $393 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan, Trulance | $493 | $60,69337 claims |
| AbbVieLinzess | $1,079 | $32,57961 claims |
| Phathom Pharmaceuticals, Inc.Voquezna | $56 | $9,20015 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Motegrity | $189 | $7,73415 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 1,885 gastroenterology providers in California.
Other gastroenterology in Santa Monica
- Peter WinkleCypress$116.7M
- Manuchehr DaraniSanta Ana$17.7M
- Jatinder PruthiLancaster$4.4M
- Long DangWestminster$4.3M
- Muhammad SheikhFresno$4.3M
- Gregory WienerChula Vista$3.5M
- Gil MelmedLos Angeles$3M
- Christopher BowlusSacramento$3M
- Bennett RothLos Angeles$2.8M
- Brigid BolandSan Diego$2.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.